Objective: The objective of this study was todirectly assess the likelihood and timing of alphablocker discontinuation in patients receivingcombination therapy with dutasteride orfinasteride plus an ...

Credit: Getty Images. Study findings suggest clinicians may safely prescribe alpha blockers to help manage hypertension in patients receiving hemodialysis. Alpha blockers do not increase the risk for ...

Men with benign prostatic hyperplasia (BPH) who took alpha-blockers to manage the condition were roughly 50% more likely to develop acute angle-closure glaucoma than were those who did not use the ...

: To evaluate the likelihood of alphaadrenergic antagonist (alpha-blocker) discontinuation in combination with dutasteride or finasteride among patients aged =65 years with enlarged prostate. Methods ...

A new trial adds to evidence that alpha-blockers do not expedite the passage of ureteral stones in patients who present with renal colic compared with placebo, although stone size may matter. "Use of ...

This study investigated trends in the prescription of α-blockers for patients with BPH, focusing on changing patterns of prescriptions during 2002–2013 using National Health Insurance Service-National ...

Alpha-blocker therapy does not decrease the risk for prostate cancer death, but it is associated with an elevated risk for low-grade prostate cancer. Preclinical studies have suggested that ...

Dear Dr. Roach: I’m a 73-year-old male in good health. I’m starting to show signs of prostate troubles. I have trouble starting to urinate, and the stream stops and starts, usually at night before bed ...

Please provide your email address to receive an email when new articles are posted on . Patients taking alpha blockers had no significant increased risk for fractures after 2 years. Alpha blocker use ...

Alpha-blockers and Alpha-2 agonists are not recommended as first-choice treatment for high blood pressure. Beta-blockers can worsen asthma symptoms and other lung conditions. Vasodilators and loop ...

The FDA has notified healthcare professionals that the Boxed Warning for the tumor necrosis factor-alpha (TNF-alpha) blocker class of drugs has been updated to include the risk of infection from ...